Eden Research Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Sean Smith

Chief Executive Officer (CEO)

UK£360.4k

Compensación total

Porcentaje del salario del CEO	75.8%
Permanencia del CEO	9.7yrs
Participación del CEO	0.2%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	9.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Sean Smith en comparación con los beneficios de Eden Research?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	-UK£6m
Sep 30 2023	n/a	n/a	-UK£7m
Jun 30 2023	n/a	n/a	-UK£7m
Mar 31 2023	n/a	n/a	-UK£5m
Dec 31 2022	UK£360k	UK£273k	-UK£2m
Sep 30 2022	n/a	n/a	-UK£2m
Jun 30 2022	n/a	n/a	-UK£2m
Mar 31 2022	n/a	n/a	-UK£2m
Dec 31 2021	UK£739k	UK£253k	-UK£3m
Sep 30 2021	n/a	n/a	-UK£3m
Jun 30 2021	n/a	n/a	-UK£3m
Mar 31 2021	n/a	n/a	-UK£3m
Dec 31 2020	UK£421k	UK£235k	-UK£2m
Sep 30 2020	n/a	n/a	-UK£2m
Jun 30 2020	n/a	n/a	-UK£2m
Mar 31 2020	n/a	n/a	-UK£1m
Dec 31 2019	UK£349k	UK£212k	-UK£1m
Sep 30 2019	n/a	n/a	-UK£594k
Jun 30 2019	n/a	n/a	-UK£44k
Mar 31 2019	n/a	n/a	-UK£189k
Dec 31 2018	UK£353k	UK£190k	-UK£335k
Sep 30 2018	n/a	n/a	-UK£1m
Jun 30 2018	n/a	n/a	-UK£2m
Mar 31 2018	n/a	n/a	-UK£1m
Dec 31 2017	UK£258k	UK£147k	-UK£639k

Compensación vs. Mercado: La compensación total ($USD450.75K) de Sean está en línea con el promedio de empresas de tamaño similar en el mercado German ($USD406.04K).

Compensación vs. Ingresos: La compensación de Sean ha sido consistente con los resultados de la empresa en el último año.

CEO

Sean Smith (56 yo)

9.7yrs

Permanencia

UK£360,376

Compensación

Mr. Sean Michael Smith has been the Chief Executive Officer of Eden Research PLC since September 1, 2014. Mr. Smith served as the Head of Europe and Innovation Advisor at Intellectual Ventures - Invention...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Sean Smith	CEO & Executive Director	9.7yrs	UK£360.38k	0.22% £ 59.6k
Alexander Abrey	CFO, Secretary & Executive Director	16.7yrs	UK£270.64k	0.33% £ 88.7k
Gary Ostroff	Member of Scientific Advisory Board	no data	sin datos	sin datos
Robin James Cridland	Independent Non-Executive Director	9yrs	UK£40.00k	0.14% £ 37.3k
Lykele van der Broek	Independent Non-Executive Chairman	6.6yrs	UK£45.00k	0.30% £ 81.1k
Richard Smart	Member of Scientific Advisory Board	no data	sin datos	sin datos
Paul Williams	Member of Scientific Advisory Board	no data	sin datos	sin datos
Chung-Jan Chang	Member of Scientific Advisory Board	no data	sin datos	sin datos

9.3yrs

Permanencia media

56yo

Promedio de edad

Junta con experiencia: La junta directiva de 9T7 se considera experimentada (9.3 años de antigüedad promedio).

Eden Research Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Eden Research plc Announces Appointment of Derek Mcallan as Non-Executive Director and as Chairman of the Audit Committee Following the Company's 2024 AGM

Insufficient new directors

Eden Research plc Announces Richard Horsman to Stepped Down as Non-Executive Director

Eden Research plc, Annual General Meeting, Jun 29, 2023

Less than half of directors are independent

Eden Research plc Appoints Richard Horsman as Non-Executive Director, with effect from 1 September 2022

Recent updates

Eden Research plc to Report Fiscal Year 2023 Results on May 07, 2024

Eden Research plc Announces Appointment of Derek Mcallan as Non-Executive Director and as Chairman of the Audit Committee Following the Company's 2024 AGM

New major risk - Revenue and earnings growth

Full year 2023 earnings released: UK£0.015 loss per share (vs UK£0.006 loss in FY 2022)

New minor risk - Financial data availability

Insufficient new directors

Eden Research plc Announces Richard Horsman to Stepped Down as Non-Executive Director

Eden Research plc Provides Revenue Guidance for the Full Year of 2023

First half 2023 earnings released: UK£0.015 loss per share (vs UK£0.003 loss in 1H 2022)

Eden Research plc to Report First Half, 2023 Results on Sep 29, 2023

New major risk - Revenue and earnings growth

New minor risk - Shareholder dilution

Eden Research plc Announces Regulatory Application for Authorised Use of Ecovelex™ in the United Kingdom

Eden Research plc, Annual General Meeting, Jun 29, 2023

Full year 2022 earnings released: UK£0.006 loss per share (vs UK£0.007 loss in FY 2021)

Eden Research plc to Report Fiscal Year 2022 Results on May 05, 2023

Eden Research plc Announces First Mevalone Authorisation for Domestic Use

Eden Research plc Provides Revenue Guidance for the Full Year of 2022

Less than half of directors are independent

First half 2022 earnings released: EPS: UK£0 (vs UK£0.004 loss in 1H 2021)

Eden Research plc Grants US EPA Regulatory Approval

Eden Research plc Appoints Richard Horsman as Non-Executive Director, with effect from 1 September 2022

Eden Research plc, Annual General Meeting, Jun 29, 2022

Full year 2021 earnings released: UK£0.007 loss per share (vs UK£0.007 loss in FY 2020)

Eden Research plc Announces Progress Towards EPA Approval and Further Authorisation in Italy

Insufficient new directors

First half 2021 earnings released: UK£0.004 loss per share (vs UK£0.004 loss in 1H 2020)

Eden Research plc Announces New Label Extension for Biofungicide in Portugal

Full year 2020 earnings released: UK£0.007 loss per share (vs UK£0.005 loss in FY 2019)

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Miembros de la Junta

Permanencia media

Promedio de edad